BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 17, 2019
View Archived Issues
"Neoleukins" better than the real thing
Read More
"Exercise hormone" has role in synaptic plasticity, memory
Read More
KPNA1 influences sphingosine-sensitive anxiety pathways by regulating MeCP2 nuclear import
Read More
Orion Biotechnology's OB-002O reduces colorectal tumor growth in vivo
Read More
Novel insights into targets and mechanisms behind the neuroprotective effect of N-Acetylcysteine
Read More
VISTA found a potential therapeutic target in pancreatic cancer
Read More
Biomunex and Sanofi enter licensing agreement for bi- and multi-specific antibody therapeutics
Read More
Anti-CTLA-4 dual variable domain preserves antitumor effects while eliminating toxicity
Read More
EMA grants marketing authorization for macimorelin
Read More
Erleada approved in Europe for patients with nmCRPC at high risk of developing metastatic disease
Read More
Phase IIa study of UB-311 meets primary endpoint in patients with Alzheimer's disease
Read More
Pulmotect initiates phase II study of PUL-042
Read More
Top-line data presented from phase II study of NYX-2925 in painful diabetic peripheral neuropathy
Read More
How chondrocytes make the best of low-oxygen state
Read More
Chinfloxacin shows promising PK and safety profile in first-in-human study
Read More
Dual PI3K/HDAC inhibitors discovered at the U.S. Department of Health & Human Services
Read More
Macrophage integrin CD11b as novel therapeutic target for cancer immunotherapy
Read More
Ralexar Therapeutics patents oxysterols receptor LXR-beta agonists
Read More
FDA issues complete response letter for Opsumit sNDA for CTEPH
Read More
FDA clears IND for phase Ib study of Aivita's AV-MEL-1 in metastatic melanoma
Read More
Pharmaxis eyes phase II studies with LOXL2 inhibitors following completion of toxicity studies
Read More
ADC Therapeutics begins phase I trial of ADCT-601 in advanced or metastatic solid tumors
Read More
FDA accepts IND for phase Ib/IIa study of Hyleukin-7 with atezolizumab in high-risk skin cancers
Read More
Celleron completes phase Ib evaluation of CXD-101 with nivolumab
Read More